Archives for July 4, 2017

← 2017

WCT selected to conduct Ph III NurOwn Trial in ALS

By Melissa Fassbender

BrainStorm Cell Therapeutics has contracted Worldwide Clinical Trials (WCT) to conduct its planned Phase III study of NurOwn in the treatment of amyotrophic lateral sclerosis (ALS).